KRON — Kronos Bio Cashflow Statement
0.000.00%
Last trade - 00:00- $43.00m
- -$69.43m
- $9.85m
- 34
- 38
- 43
- 31
Annual cashflow statement for Kronos Bio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -88.4 | -151 | -133 | -113 | -86.1 |
| Depreciation | |||||
| Non-Cash Items | 43.2 | 32.8 | 33.8 | 26.1 | 36.8 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 6.46 | -1.62 | 6.18 | 5.88 | -17.9 |
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -37.9 | -118 | -90.9 | -78.6 | -65.4 |
| Capital Expenditures | -9.57 | -4.26 | -0.577 | -0.679 | -0.004 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -151 | 68 | -31.6 | 67 | 85.4 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -160 | 63.7 | -32.2 | 66.4 | 85.4 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 416 | 4.46 | 0.851 | 0.567 | 0.245 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 217 | -49.7 | -122 | -11.6 | 20.2 |